Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Paracetamol-inhibitable COX-2.

R Botting1

  • 1The William Harvey Research Institute, St Bartholomew's and the Royal London Medical and Dental School, UK.

Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Directions in rheumatology: past, present and future. Report of a conference to celebrate the 50th anniversary of the Oliver Bird Fund held at Churchill College Cambridge, 24-26 September 1998.

Rheumatology (Oxford, England)·1999
Same author

Re-addressing relative selectivities.

Trends in pharmacological sciences·1997
Same author

Endothelin: a knockout in London.

Trends in pharmacological sciences·1995
Same author

Modulation of platelet function by free radicals and free-radical scavengers.

Trends in pharmacological sciences·1993
Same author

Mediators from the endothelial cell.

Advances in prostaglandin, thromboxane, and leukotriene research·1991
Same author

Vasoactive mediators derived from the endothelium.

Archives des maladies du coeur et des vaisseaux·1989
Same journal

Danggui Shaoyao San alleviates nephrotic syndrome by regulating inerleukin 13/signal transducer and activator of transcription 6 axis.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2026
Same journal

Effect of short-term of vaginal therapy with prasterone before urogynecological surgery in woman.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2026
Same journal

Parthenolide ameliorates metabolic dysfunction-associated steatohepatitis by inhibiting M1 polarization by suppressing the nuclear factor-κB pathway.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2026
Same journal

Glutamyl-tRNA synthetase 2 regulates mitochondrial biogenesis and reactive oxygen species homeostasis mediatingenzalutamide resistance by targeting striatin 4 in prostate cancer cells.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2026
Same journal

Regulation of the KEAP1/NRF2 pathway by claudin-2-targeted lymphoid enhancer-binding factor 1 binding in gastric cancer progression.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2026
Same journal

Mulberry leaf supplementation improves glycemic control but not renal or cardiovascular markers in spontaneously hypertensive rats.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2026
See all related articles

Paracetamol effectively treats pain and fever, but its mechanism remains unclear. Research suggests paracetamol may inhibit a specific COX-2 variant or enzyme involved in inflammation resolution.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Immunology

Background:

  • Paracetamol (acetaminophen) is a widely used analgesic and antipyretic.
  • Its precise mechanism of action, particularly its in vivo effects on prostaglandin synthesis despite weak in vitro cyclooxygenase (COX) inhibition, is not fully understood.

Purpose of the Study:

  • To investigate the mechanism of action of paracetamol, focusing on its interaction with cyclooxygenase enzymes.
  • To explore the potential role of a specific COX-2 variant or enzyme in paracetamol's effects.

Main Methods:

  • Experiments using mouse macrophage J774.2 cells to assess COX-2 inhibition by paracetamol.
  • Utilizing a rat pleurisy model to study the role of COX-2 during inflammation resolution.
  • Investigating COX-2 activity in cultured lung fibroblasts stimulated with IL-1beta.

Related Experiment Videos

Main Results:

  • Paracetamol demonstrated higher sensitivity in inhibiting NSAID-induced COX-2 in macrophages compared to endotoxin-induced COX-2.
  • A distinct peak of COX-2 protein during the resolution phase of inflammation in rats was observed.
  • Inhibition of this late-phase COX-2 prolonged inflammation, indicating its role in resolution.
  • IL-1beta-stimulated COX-2 in lung fibroblasts was highly sensitive to paracetamol.

Conclusions:

  • Evidence suggests paracetamol may target a specific COX-2 variant or a novel COX enzyme.
  • This enzyme appears to play a crucial role in the resolution of inflammation.